Assessing the Risk of De Novo Malignancy in Kidney Transplant Recipients: Role for Monitoring of Peripheral Blood Lymphocyte Populations

被引：4
|
作者：
Fernandez-Ruiz, Mario [1 ]
Lopez-Medrano, Francisco [1 ]
Allende, Luis M. [2 ]
Andres, Amado [3 ]
Paz-Artal, Estela [2 ]
Maria Aguado, Jose [1 ]
机构：
[1] Hosp Univ 12 Octubre, Inst Invest, Infect Dis Unit, Madrid 28041, Spain
[2] Hosp Univ 12 Octubre, Inst Invest, Dept Immunol, Madrid 28041, Spain
[3] Hosp Univ 12 Octubre, Inst Invest, Dept Nephrol, Madrid 28041, Spain
来源：
TRANSPLANTATION | 2014年 / 98卷 / 05期
关键词：
CELL-DEPLETING ANTIBODIES; SUBSETS; CANCER;
D O I：
10.1097/TP.0000000000000297
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：E36 / E37
页数：2
相关论文
共 50 条
  • [31] DE NOVO DONOR-SPECIFIC HLA ANTIBODIES IN LOW RISK PEDIATRIC KIDNEY TRANSPLANT RECIPIENTS
    Yilmaz, Alev
    Oguz, Fatma Savran
    Usta, Sebahat
    Yildirim, Zeynep Yuruk
    Pehlivanoglu, Cemile
    Kekik, Cigdem
    Emre, Sevinc
    PEDIATRIC NEPHROLOGY, 2015, 30 (09) : 1724 - 1724
  • [32] De Novo Post-Transplant Malignancy among Solid Organ Transplant Recipients in the United States
    Cho, Y. W.
    Sampaio, M. S.
    Qazi, Y.
    Hutchinson, I. V.
    Shah, T.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2011, 11 : 510 - 510
  • [33] De novo malignancy in organ transplant recipients in Taiwan: a nationwide cohort population study
    Tsai, Hsin-I
    Lee, Chao-Wei
    Kuo, Chang-Fu
    See, Lai-Chu
    Liu, Fu-Chao
    Chiou, Meng-Jiun
    Yu, Huang-Ping
    ONCOTARGET, 2017, 8 (22) : 36685 - 36695
  • [34] DE NOVO DONOR-SPECIFIC HLA ANTIBODIES IN LOW RISK PEDIATRIC KIDNEY TRANSPLANT RECIPIENTS
    Yilmaz, A.
    Yildirim, Z. Yuruk
    Pehlivanoglu, C.
    Nayir, A.
    Emre, S.
    Savran, F. Oguz
    Usta, S.
    Kekik, C.
    PEDIATRIC TRANSPLANTATION, 2015, 19 : 125 - 125
  • [35] Impact of the Type of Induction Therapy on the Kinetics of Peripheral Blood Lymphocyte Subpopulations (PBLS) and the Risk of Infection in Kidney Transplant (KT) Recipients.
    Fernandez-Ruiz, M.
    Lopez-Medrano, F.
    Allende, L. M.
    Polanco, N.
    Garcia-Reyne, A.
    Andres, A.
    Lumbreras, C.
    San Juan, R.
    Morales, J. M.
    Paz-Artal, E. M.
    Aguado, J. M.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 : 314 - 314
  • [36] Immunosuppression and the risk of post transplant malignancy among cadaveric kidney transplant recipients.
    Port, FK
    Bustami, RT
    Wolfe, RA
    Leichtman, AB
    Merion, RM
    Ojo, AO
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 : 369A - 369A
  • [37] Monitoring of immune function for treatment of post-transplant de novo malignancy
    Uemura, Tadahiro
    Riley, Thomas R., III
    Khan, Akhtar
    Schreibman, Ian
    Hollenbeak, Christopher
    Kwon, Osun
    Ghahramani, Nasrollah
    Reeves, Brian
    Domen, Ronald E.
    Zander, Dani S.
    Kadry, Zakiyah
    AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 : 479 - 479
  • [38] De Novo Colorectal and Pancreatic Cancer in Liver-Transplant Recipients: Identifying the Higher-Risk Populations
    Nasser-Ghodsi, Navine
    Mara, Kristin
    Watt, Kymberly D.
    HEPATOLOGY, 2021, 74 (02) : 1003 - 1013
  • [39] Effect of denosumab on trabecular bone score in de novo kidney transplant recipients
    Bonani, Marco
    Frey, Diana
    Graf, Nicole
    Wuthrich, Rudolf P.
    SWISS MEDICAL WEEKLY, 2018, 148 : 16S - 16S
  • [40] Infections in De Novo Kidney Transplant Recipients Treated With the RANKL Inhibitor Denosumab
    Bonani, Marco
    Frey, Diana
    de Rougemont, Olivier
    Mueller, Nicolas J.
    Mueller, Thomas F.
    Graf, Nicole
    Wuthrich, Rudolf P.
    TRANSPLANTATION, 2017, 101 (09) : 2139 - 2145
12345